THE BIG READ | The development that could be the beginning of the end for Alzheimer's

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
It's estimated that there are 44 million people worldwide living with Alzheimer's. A new development offers the first glimmer of hope that the disease can be cured. (PHOTO: Gallo Images / Getty Images)
It's estimated that there are 44 million people worldwide living with Alzheimer's. A new development offers the first glimmer of hope that the disease can be cured. (PHOTO: Gallo Images / Getty Images)

It was a breakthrough moment: the recent announcement that a new Alzheimer’s drug, the first for 20 years, has been approved for use in America. John Hardy, the scientist behind it, speaks about what the development means for people who have the disease.

Almost four decades ago a desperate woman sent John Hardy a letter.

“Dear Sir,” Carol Jennings, from Nottingham in England, wrote in her careful handwriting. “I was very interested to read of your research in the Alzheimer’s Disease Society News and think my family could be of use.”

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in